Article Details
Retrieved on: 2025-08-09 01:11:47
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Sarepta reported a quarter-on-quarter dip in sales for its Duchenne gene therapy, while the neuroscience-focused biotech Neumora said it plans to test ...
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here